Gilead Sciences, Inc.
Apoptosis signal-regulating kinase inhibitor
Last updated:
Abstract:
The present invention relates to a compound of formula (I): ##STR00001## The compound has apoptosis signal-regulating kinase ("ASK1") inhibitory activity, and is thus useful in the treatment of diseases such as kidney disease, diabetic nephropathy and kidney fibrosis.
Status:
Grant
Type:
Utility
Filling date:
11 Jan 2019
Issue date:
17 Dec 2019